Researchers from VIB, VUB, and international partners have developed the most extensive single-cell atlas of tumor-associated dendritic cells, offering insights into immune cell organization in cancer.
Researchers from VIB (Flanders Institute for Biotechnology), VUB (Vrije Universiteit Brussel), and an international network of collaborators have made significant strides in understanding how key immune cells behave within tumors. In a groundbreaking study published in Nature Communications, they created the most comprehensive single-cell atlas to date of tumor-associated dendritic cells.
By integrating data from 14 mouse tumor models and 10 human cancer types, this extensive research provides a detailed, cross-species view of these critical immune cells. Dendritic cells play a pivotal role in the body's immune response, and their altered state within tumors can significantly impact treatment outcomes. The new atlas offers valuable insights into how dendritic cells are organized and modified in various cancers.
This comprehensive atlas will be instrumental in guiding the development of next-generation therapies that target these immune cells more effectively. Understanding the complex interactions between dendritic cells and cancer could lead to breakthroughs in immunotherapy, potentially improving patient outcomes across multiple types of cancer.
